On September 11, join Caidya for the panel, “China Clinical Capability as a Global Value-Creation Driver: Opportunities and Challenges.” The discussion will be moderated by Miron Lila, Chief Corporate Development Officer at Caidya, with Susan Kong, VP Regulatory & Strategic Development at Caidya, joining as a panelist.
The session will explore how China’s clinical capabilities can contribute to global value creation, as well as the opportunities and challenges companies should consider when connecting China with broader global development strategies.
Meet the Caidya team at BIOHK 2026 to discuss your China and global clinical development plans.